Antineoplastic agent- a recombinant humanized anti-human epidermal growth factor receptor type 2 (anti-her2/erbb2) monoclonal antibody.uses for pertuzumab:-**breast cancerin combination with trastuzumab and docetaxel for the treatment of metastatic breast cancer in patients whose tumors overexpress the her2 protein and who have not received prior anti-her2 therapy or chemotherapy for metastatic disease.efficacy established based on progression-free survival- effect on overall survival not established.rate of administrationinitial dose: administer over 60 minutes.subsequent doses: administer over 30-60 minutes.
المزيد من التفاصيل